Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function

J Med Chem. 2022 Nov 24;65(22):15391-15415. doi: 10.1021/acs.jmedchem.2c01350. Epub 2022 Nov 16.

Abstract

Polyamine biosynthesis is regulated by ornithine decarboxylase (ODC), which is transcriptionally activated by c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO). Anthranilic acid derivatives were identified as DFMO adjunct agents. Further studies identified the far upstream binding protein 1 (FUBP1) as the target of lead compound 9. FUBP1 is a single-stranded DNA/RNA binding protein and a master controller of specific genes including c-Myc and p21. We showed that 9 does not inhibit 3H-spermidine uptake yet works synergistically with DFMO to limit cell growth in the presence of exogenous spermidine. Compound 9 was also shown to inhibit the KH4 FUBP1-FUSE interaction in a gel shift assay, bind to FUBP1 in a ChIP assay, reduce both c-Myc mRNA and protein expression, increase p21 mRNA and protein expression, and deplete intracellular polyamines. This promising hit opens the door to new FUBP1 inhibitors with increased potency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eflornithine* / pharmacology
  • RNA, Messenger / genetics
  • RNA-Binding Proteins
  • Spermidine* / metabolism

Substances

  • anthranilic acid
  • Eflornithine
  • RNA, Messenger
  • RNA-Binding Proteins
  • Spermidine
  • FUBP1 protein, human